Microbiological profiles and antibiotic resistance of periprosthetic joint infection after hip replacement in patients with fracture or non-fracture: A comparative study
Restricted accessResearch articleFirst published online January, 2023
Microbiological profiles and antibiotic resistance of periprosthetic joint infection after hip replacement in patients with fracture or non-fracture: A comparative study
Periprosthetic joint infection (PJI) is one of the worst complications following total joint arthroplasty (TJA). Unfortunately, effective prevention strategies to reduce the burden of PJI have not been fully determined in hip replacement patients with fracture and non-fracture.
OBJECTIVE:
This study aimed to analyze and compare the demographic characteristics, microbiological profiles and antibiotic resistance of PJI after hip replacement between patients with fracture and non-fracture.
METHODS:
We retrospectively analyzed the data of 132 patients who treated PJI. There were divided into two groups: non-fracture group (64 patients infected after hip replacement for fracture) and non-fracture group (68 patients infected after hip replacement for non-fracture). Microorganisms were obtained from the synovial fluid and infected necrotic tissue in the joint capsule, medullary cavity, or acetabulum in all patients, and microbiological profiles and antibiotic resistance were evaluated.
RESULTS:
Coagulase-negative staphylococci (CoNS) were the most common pathogenic microorganisms in all patients. Methicillin-resistant Staphylococcus (MRS) accounted for 25% in all pathogenic microbes. Staphylococci showed high drug resistance rates to clindamycin, levofloxacin, and all of the first- and second-generation cephalosporins. MRS isolates in non-fracture group had higher drug resistance rates to clindamycin and levofloxacin than than those in fracture group. Gram-negative bacilli (GNB) showed high drug resistance rates to Aztreonam, gentamicin and all of the third- and fourth-generation cephalosporins. Furthermore, GNB isolates in the non-fracture group showed higher resistance rates to gentamicin and all of the third- and fourth-generation cephalosporins.
CONCLUSIONS:
MRS isolates in the non-fracture group showed higher drug resistance rates to clindamycin and levofloxacin, and GNB isolates in non-fracture group showed higher drug resistance rates to gentamicin and all of the third- and fourth-generation cephalosporins.
IannottiFPratiPFidanzaAIorioRFerrettiAPèrez PrietoDKortNViolanteBPipinoGSchiavone PanniAHirschmannMMugnainiMFrancesco IndelliP. Prevention of periprosthetic joint infection (PJI): A clinical practice protocol in high-risk patients. Trop Med Infect Dis.2020; 5(4): 186. doi: 10.3390/tropicalmed5040186.
2.
PeelTNBuisingKLChoongPF. Diagnosis and management of prosthetic joint infection. CurrOpin Infect Dis.2012; 25(6): 670-676. doi: 10.1097/QCO.0b013e32835915db.
3.
OsmonDRBerbariEFBerendtARLewDZimmerliWSteckelbergJM, et al. Infectious diseases society of america. Diagnosis and management of prosthetic joint infection: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis.2013; 56(1): e1-e25. doi: 10.1093/cid/cis803.
Rodríguez-PardoDPigrauCCoronaPSAlmiranteB. An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: New challenges for the present and the future. Expert Rev Anti Infect Ther.2015; 13(2): 249-265. doi: 10.1586/14787210.2015.999669.
6.
StefánsdóttirAJohanssonDKnutsonKLidgrenLRobertssonO. Microbiology of the infected knee arthroplasty: Report from the Swedish Knee Arthroplasty Register on 426 surgically revised cases. Scand J Infect Dis.2009; 41(11-12): 831-840. doi: 10.3109/00365540903186207.
7.
TsaiJCShengWHLoWYJiangCCChangSC. Clinical characteristics, microbiology, and outcomes of prosthetic joint infection in Taiwan. J Microbiol Immunol Infect.2015; 48(2): 198-204. doi: 10.1016/j.jmii.2013.08.007.
8.
Bjerke-KrollBTChristABMcLawhornASSculcoPKJules-ElyséeKMSculcoTP. Periprosthetic joint infections treated with two-stage revision over 14 years: An evolving microbiology profile. J Arthroplasty.2014; 29(5): 877-882. doi: 10.1016/j.arth.2013.09.053.
9.
SalgadoCDDashSCanteyJRMarculescuCE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin OrthopRelat Res.2007; 461: 48-53. doi: 10.1097/BLO.0b013e3181123d4e.
10.
HsiehPHLeeMSHsuKYChangYHShihHNUengSW. Gram-negative prosthetic joint infections: Risk factors and outcome of treatment. Clin Infect Dis.2009; 49(7): 1036-1043. doi: 10.1086/605593.
11.
BreznickyJHlavacMNovakMHrncarM. Risk factors for periprosthetic joint infection of the hip and knee. Med Glas (Zenica).2020; 17(1): 92-97.
12.
SchoofBJakobsOSchmidlSKlatteTOFrommeltLGehrkeTGebauerM. Fungal periprosthetic joint infection of the hip: A systematic review. Orthop Rev (Pavia).2015 Mar 31; 7(1): 5748.
13.
WimmerMDFriedrichMJRandauTMPloegerMMSchmoldersJStraussAA, et al. Polymicrobial infections reduce the cure rate in prosthetic joint infections: Outcome analysis with two-stage exchange and follow-up ⩾ twoyears. Int Orthop.2016; 40(7): 1367-1373. doi: 10.1007/s00264-015-2871-y.
PiperKEJacobsonMJCofieldRHSperlingJWSanchez-SoteloJOsmonDR, et al. Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonicationJ. Clin Microbiol.2009; 47(6): 1878-1884. doi: 10.1128/JCM.01686-08.
17.
KheirMMTanTLAckermanCTModiRFoltzCParviziJ. Culturing periprosthetic joint infection: Number of samples, growth duration, and organisms. J Arthroplasty.2018; 33(11): 3531-3536.e1. doi: 10.1016/j.arth.2018.06.018.
18.
ZmistowskiBDella ValleCBauerTW, et al. Diagnosis of periprosthetic joint infection [published correction appears in J Arthroplasty. 2014; 29(10): 2056. Lorenzo, Drago [Corrected to Drago, Lorenzo]]. J Arthroplasty. 2014; 29(2 Suppl): 77-83. doi: 10.1016/j.arth.2013.09.04015. Aggarwal VK, Bakhshi H, Ecker NU, Parvizi J, Gehrke T, Kendoff D. Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States. J Knee Surg. 2014; 27(5): 399-406. doi: 10.1055/s-0033-1364102.
19.
BenitoNFrancoMRiberaASorianoARodriguez-PardoDSorlíLFrescoG, et al. Time trends in the etiology of prosthetic joint infections: A multicenter cohort study. Clin Microbiol Infect.2016; 22: 732. doi: 10.1016/j.cmi.2016.05.004.
20.
DragoLDe VecchiEBortolinMZagraLRomanòCLCappellettiL. Epidemiology and antibiotic resistance of late prosthetic knee and hip infections. J Arthroplasty.2017; 32(8): 2496-2500. doi: 10.1016/j.arth.2017.03.005.
21.
TsaiYChangCHLinYCLeeSHHsiehPHChangY. Different microbiological profiles between hip and knee prosthetic joint infections. J Orthop Surg (Hong Kong).2019; 27(2): 2309499019847768. doi: 10.1177/2309499019847768.
22.
de SanctisJTeixeiraLvan DuinDOdioCHallGTomfordJW, et al. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: A unique challenge in the era of untreatable infections. Int J Infect Dis.2014; 25: 73-78. doi: 10.1016/j.ijid.2014.01.028.
23.
SendiPFreiRMaurerTBTrampuzAZimmerliWGraberP. Escherichia coli variants in periprosthetic joint infection: Diagnostic challenges with sessile bacteria and sonication. J Clin Microbiol.2010; 48(5): 1720-1725. doi: 10.1128/JCM.01562-09.
24.
AzzamKParviziJJungkindDHanssenAFehringTSpringerB, et al. Microbiological, clinical, and surgical features of fungal prosthetic joint infections: A multi-institutional experienceJ. Bone Joint Surg Am.2009; 91(Suppl 6): 142-149. doi: 10.2106/JBJS.I.00574.
25.
LentinoJR. Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis.2003; 36(9): 1157-1161. doi: 10.1086/374554.
26.
LangvatnHLutroODaleHSchramaJCHallanGEspehaugB, et al. Bacterial and hematological findings in infected total hip arthroplasties in norway assessment of 278 revisions due to infection in the norwegian arthroplasty register. Open Orthop J.2015; 9: 445-449. Published 2015 Sep 30. doi: 10.2174/1874325001509010445.
27.
KavolusJJCunninghamDJRaoSRWellmanSSSeylerTM. Polymicrobial infections in hip arthroplasty: Lower treatment success rate, increased surgery, and longer hospitalization. J Arthroplasty.2019; 34(4): 710-716.e3. doi: 10.1016/j.arth.2018.09.090.
TanTLKheirMMShohatNTanDDKheirMChenC, et al. Culture-negativeperiprosthetic joint infection: An update on what to expect. JB JS Open Access.2018; 3(3): e0060. Published 2018 Jul 12. doi: 10.2106/JBJS.OA.17.00060.
30.
HuFZhuDWangFWangM. Current status and trends of antibacterial resistance in China. Clin Infect Dis.2018; 67(suppl_2): S128-S134. doi: 10.1093/cid/ciy657.
31.
RaviSZhuMLueyCYoungSW. Antibiotic resistance in early periprosthetic joint infection. ANZ J Surg.2016; 86(12): 1014-1018.
32.
ScholtenRKlein KlouwenbergPMCGisolfJEHvan SusanteJLCSomfordMP. Empiric antibiotic therapy in early periprosthetic joint infection: a retrospective cohort study. Eur J Orthop Surg Traumatol. 2021. doi: 10.1007/s00590-021-03156-0. Online ahead of print.
33.
Rodríguez-PardoDPigrauCLora-TamayoJSorianoAdel ToroMDCoboJ, et al. Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect.2014; 20(11): O911-O919. doi: 10.1111/1469-0691.12649.
34.
TsaiYChangCHLinYCLeeSHHsiehPHChangY. Different microbiological profiles between hip and knee prosthetic joint infections. J Orthop Surg (Hong Kong).2019; 27(2): 2309499019847768.
